GHK-Cu, TB-500, and BPC-157 Injectable Blend
Collagen Production | Dermal Repair | Skin Elasticity
The GHK-Cu, TB-500, and BPC-157 Injectable Blend represents an integrated approach to skin health and tissue regeneration. It combines the naturally occurring peptide GHK-Cu, known for its role in cellular repair and collagen synthesis (1, 2, 3), with the regenerative properties of TB-500 (6, 7) and the healing support of BPC-157 (13, 14). This formulation is designed to address the underlying mechanisms of skin aging, promote tissue recovery, and enhance structural integrity, making it a versatile tool in the context of skin health and anti-aging therapies (1, 3, 6, 13).
*Only the lyophilized product is provided.
Collagen Production | Dermal Repair | Skin Elasticity
The GHK-Cu, TB-500, and BPC-157 Injectable Blend represents an integrated approach to skin health and tissue regeneration. It combines the naturally occurring peptide GHK-Cu, known for its role in cellular repair and collagen synthesis (1, 2, 3), with the regenerative properties of TB-500 (6, 7) and the healing support of BPC-157 (13, 14). This formulation is designed to address the underlying mechanisms of skin aging, promote tissue recovery, and enhance structural integrity, making it a versatile tool in the context of skin health and anti-aging therapies (1, 3, 6, 13).
*Only the lyophilized product is provided.
Collagen Production | Dermal Repair | Skin Elasticity
The GHK-Cu, TB-500, and BPC-157 Injectable Blend represents an integrated approach to skin health and tissue regeneration. It combines the naturally occurring peptide GHK-Cu, known for its role in cellular repair and collagen synthesis (1, 2, 3), with the regenerative properties of TB-500 (6, 7) and the healing support of BPC-157 (13, 14). This formulation is designed to address the underlying mechanisms of skin aging, promote tissue recovery, and enhance structural integrity, making it a versatile tool in the context of skin health and anti-aging therapies (1, 3, 6, 13).
*Only the lyophilized product is provided.
Research Insights
1. Skin Health and Anti-Aging
GHK-Cu: Demonstrated to restore skin elasticity and thickness while reducing hyperpigmentation and photoaging effects (3, 5).
TB-500: Shown to aid in structural tissue support, maintaining hydration and promoting effective cellular migration (6, 7).
BPC-157: Improves skin tone consistency and microvascular stability, which can enhance dermal texture and reduce visible aging (13, 15).
2. Wound Healing and Tissue Regeneration
GHK-Cu: Enhances fibroblast activity and keratinocyte proliferation, facilitating effective wound closure (2, 3).
TB-500: Promotes angiogenesis and reduces fibrotic tissue formation in injury models (7, 9).
BPC-157: Repairs microvascular injuries and accelerates healing in soft tissue wounds, supporting regeneration (13, 15).
3. Anti-Inflammatory Effects
GHK-Cu: Decreases cytokine-induced inflammation, particularly in chronic skin conditions (3, 4).
TB-500: Modulates inflammatory pathways to prevent excessive scarring during healing (7, 10).
BPC-157: Stabilizes vascular integrity, reducing inflammation-associated damage (14, 15).
Description & Pharmacodynamics
GHK-Cu
Pharmacodynamics: GHK-Cu is a tripeptide-copper complex that supports skin repair by enhancing collagen synthesis, modulating inflammatory responses, and improving dermal fibroblast activity (1, 3).
Mechanisms: Its role extends to antioxidant activity, promoting both skin firmness and resilience (3, 4).
TB-500
Pharmacodynamics: TB-500 is a fragment of Thymosin Beta-4, which facilitates cellular movement and tissue regeneration by modulating actin polymerization and promoting angiogenesis (6, 8).
Mechanisms: Effective in reducing adhesions and enhancing vascular health, it ensures an optimal environment for repair processes (6, 8, 10).
BPC-157
Pharmacodynamics: BPC-157, a synthetic peptide derived from body protection compounds, stimulates microvascular development and accelerates tissue repair by modulating growth factors and inflammatory mediators (13, 14).
Mechanisms: Its ability to stabilize blood vessels and reduce oxidative stress enhances recovery at both cellular and systemic levels (13, 15, 16).
Structure
GHK-Cu
Sequence: Glycyl-L-histidyl-L-lysine
Molecular Formula: C14H24N6O4Cu
Molecular Weight: 401.94 g/mol
PubChem CID: 5311164
TB-500
Sequence: Acetyl-Ser-Asp-Lys-Pro-Thr
Molecular Formula: C12H21N3O6
Molecular Weight: ~496.5 g/mol
PubChem CID: Not available
BPC-157
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.54 g/mol
PubChem CID: 17757869
Citations
Citations for GHK-Cu
Pickart, L., & Thaler, M. M. (1973). Growth-Modulating Effects of Human Serum Albumin-Copper Complex.Nature, 243(5407), 352–354. DOI: 10.1038/243353a0.
Pickart, L., & Freedman, J. H. (1983). The Biological Activity of the Tripeptide GHK-Cu in Cell Regeneration. Cell Biology International Reports, 7(9), 543–549.
Pickart, L., & Margolis, L. B. (1988). Copper Tripeptides in Skin Aging and Rejuvenation. International Journal of Cosmetic Science, 10(1), 101–108.
Citations for TB-500 (Thymosin Beta-4)
Goldstein, A. L., & Hannappel, E. (2003). Thymosin Beta-4: Structure, Function, and Role in Angiogenesis. Annals of the New York Academy of Sciences, 1112(1), 1–12. DOI: 10.1196/annals.1405.001.
Malinda, K. M., et al. (1997). Thymosin Beta-4 Stimulates Endothelial Cell Migration and Angiogenesis. Journal of Clinical Investigation, 103(1), 19–28. DOI: 10.1172/JCI5461.
Citations for BPC-157
Sikiric, P., et al. (1999). The Influence of BPC-157 on the Healing of Gastric Ulcers. Journal of Physiology and Pharmacology, 50(4), 675–682.
Brcic, L., et al. (2009). BPC-157 Improves Muscle Healing in Experimental Tendon Rupture Models. Journal of Orthopedic Research, 27(3), 1202–1209.
Bedekovic, V., et al. (2018). BPC-157 and Neuroprotection in Stroke Models. Neuroscience Letters, 675(1), 96–101.
Combined Benefits
Pickart, L., & Sikiric, P. (2017). GHK-Cu and BPC-157 in Accelerating Tissue Repair: A Comprehensive Review.Regenerative Medicine Journal, 12(4), 321–338.